Terence F. Kelly

President and Managing Member

Matthew T. Kelly

Vice President

Past deals in Wisconsin

Swallow Solutions

Debt Financing in 2016
Swallow Solutions is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. It focus on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.

FluGen

Venture Round in 2016
FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.

Invenra

Venture Round in 2016
Invenra Inc. is a biopharmaceutical company specializing in the discovery of biologics, particularly antibodies and their derivatives. Founded in 2011 and located in Madison, Wisconsin, Invenra utilizes a proprietary technology that integrates cell-free expression of full-length antibodies with extreme miniaturization. This innovative approach allows for the screening of a vast number of full-length antibodies in phenotypic assays, facilitating the identification of next-generation biologics. The company boasts a strong scientific foundation and a team of experts with extensive knowledge in genomics, biochemistry, and bioengineering, blending advanced basic research with practical commercial applications.

NeuWave Medical

Series C in 2015
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.

Swallow Solutions

Venture Round in 2015
Swallow Solutions is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. It focus on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.

Madison Vaccines

Series A in 2015
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.

Phoenix

Debt Financing in 2015
Phoenix designs and manufactures the highest-yielding neutron generators and commercializes nuclear technologies for practical applications. Its commitment to commercializing nuclear technologies for practical applications has inspired its long-term goal of producing clean, fusion energy. Its achievements have enabled Phoenix to market its technologies across a variety of applications within medicine, defense, and energy sectors.

Silatronix

Funding Round in 2015
Silatronix, Inc. is a company based in Madison, Wisconsin, specializing in the development of organosilicon (OS) compounds and formulations for energy storage applications. Founded in 2007, the company focuses on creating organosilicon electrolytes used in both rechargeable and non-rechargeable lithium-ion batteries, as well as in ultracapacitors. Silatronix combines expert knowledge in organosilicon chemistry with advancements in nanostructured electrodes and the electronic properties of materials, aimed at enhancing the performance and efficiency of energy storage devices. Its innovative products are integral to the evolving landscape of energy storage technology.

Phoenix

Venture Round in 2014
Phoenix designs and manufactures the highest-yielding neutron generators and commercializes nuclear technologies for practical applications. Its commitment to commercializing nuclear technologies for practical applications has inspired its long-term goal of producing clean, fusion energy. Its achievements have enabled Phoenix to market its technologies across a variety of applications within medicine, defense, and energy sectors.

FluGen

Debt Financing in 2014
FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.

Madison Vaccines

Series A in 2014
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.

Swallow Solutions

Funding Round in 2013
Swallow Solutions is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. It focus on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.

Silatronix

Venture Round in 2013
Silatronix, Inc. is a company based in Madison, Wisconsin, specializing in the development of organosilicon (OS) compounds and formulations for energy storage applications. Founded in 2007, the company focuses on creating organosilicon electrolytes used in both rechargeable and non-rechargeable lithium-ion batteries, as well as in ultracapacitors. Silatronix combines expert knowledge in organosilicon chemistry with advancements in nanostructured electrodes and the electronic properties of materials, aimed at enhancing the performance and efficiency of energy storage devices. Its innovative products are integral to the evolving landscape of energy storage technology.

SOLOMO Technology

Series A in 2013
SOLOMO Technology Inc. specializes in indoor location intelligence and personalized marketing solutions for retailers. The company offers the SOLOMO Exchange, a web-services platform that integrates with retailers' mobile applications to collect customer identity and location data, facilitating personalized offers while prioritizing customer control over their information. Its suite of tools includes SOLOMO Geo, which provides location-based notifications and usage reports, and SOLOMO Identity, enabling customers to manage their data. Additionally, SOLOMO offers Single Sign On for secure authentication and SOLOMO Intent for users to communicate their intentions to trusted organizations. The company also develops branded in-store mobile applications that enhance customer engagement and assist sales associates in providing better service. Founded in 2010 and based in Madison, Wisconsin, SOLOMO Technology focuses on delivering effective mobile solutions that enhance the retail experience while fostering customer trust.

Swallow Solutions

Series A in 2013
Swallow Solutions is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. It focus on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.